In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...
A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
The Sixth Circuit on Friday wiped out a $650 million judgment and corresponding injunction against CVS Pharmacy Inc., Walgreens Boots Alliance Inc., and Walmart Inc. after the Ohio Supreme Court ruled ...
In an era where consumers are increasingly concerned about ethical sourcing and labor practices, the California Transparency ...
Rights Nov 19, 2007 Nov 26, 2007 Feb 12, 2007 Rights ratio: 1 share for every 1 held at a price of Rs 250.0 Bonus Nov 29, 2004 Nov 30, 2004 Jun 07, 2004 Bonus Ratio: 2 share(s) for every 1 shares held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback